Medeon Biodesign, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was TWD 43.34 million compared to TWD 190.54 million a year ago. Net loss was TWD 173.68 million compared to net income of TWD 67.17 million a year ago.

Basic loss per share from continuing operations was TWD 1.8857 compared to basic earnings per share from continuing operations of TWD 0.7333 a year ago. Diluted loss per share from continuing operations was TWD 1.8857 compared to diluted earnings per share from continuing operations of TWD 0.7238 a year ago.